Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator



HCT 3012 is indicated for the treatment of acute and chronic nociceptive pain, such as post-operative and arthritic pain. (Source: ABPI)


Back to Project Details



Related Projects

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Lipitor / Torcetrapib - Combination Therapy
Under development by Pfizer, torcetrapib is a member of the cholesteryl...

Exanta - Oral Direct Thrombin Inhibitor for the
Exanta (ximelagatran) is an oral Direct Thrombin Inhibitor (DTI)...

See all projects


Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.

cachename:Projectscachekey:rd287061489_-1402072053_rd221744618_-1992266496_rd-1665407042_-1874280820_rd-488908060_-173330816_